Science Translational Medicine
20 May 2020 Vol 12, Issue 544
https://stm.sciencemag.org/

Research Articles
An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria
By Isaie J. Reuling, António M. Mendes, Gerdie M. de Jong, Amanda Fabra-García, Helena Nunes-Cabaço, Geert-Jan van Gemert, Wouter Graumans, Luc E. Coffeng, Sake J. de Vlas, Annie S. P. Yang, Cynthia Lee, Yimin Wu, Ashley J. Birkett, Christian F. Ockenhouse, Rob Koelewijn, Jaap J. van Hellemond, Perry J. J. van Genderen, Robert W. Sauerwein, Miguel Prudêncio
Science Translational Medicine20 May 2020 Full Access
Clinical evaluation of genetically modified rodent malaria parasites for whole-sporozoite immunization against P. falciparum in healthy volunteers.